The Virtual Twin experience of the manufacturing process will add considerable value to any pharmaceutical or biotech organization by facilitating collaboration, risk analyses, change assessments, predictive simulations and support for many more activities.
The value of the virtual twin in discrete manufacturing has been shown to include significant benefits such as:
- 34% product quality improvements
- 30% reduced manufacturing costs
- 28% reduced unplanned downtime
- 25% increased throughput
Download our whitepaper to find out more!